Clinical Trial Update: Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the impact of GLP-1 receptor agonists on cardiac function, epicardial adipose tissue volume, and myocardial triglyceride content in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Obesity, Diabetes | Phase 3 | Status: COMPLETED